POET Technologies: June’s Tightrope Between a Shareholder Vote and a Class-Action Deadline

POET faces twin deadlines on June 26 and 29: shareholder vote on US redomicile and lead plaintiff cutoff in securities class action, while pursuing massive $400M production expansion for AI data centers.

The coming fortnight will test whether POET Technologies can keep the story centred on its photonics push for AI data centres. Two events—a shareholder meeting on 26 June and a lead-plaintiff deadline in a securities class action on 29 June—have squeezed the company’s governance, legal and commercial narratives into the same busy calendar window. The stock, which closed at €10.48 on Friday, has fallen 12.23% over the past week but still shows a year-to-date gain of 71.24%. The 52-week range tells a similar tale of extremes: a high of €18.84 hit on 15 May and a low of €3.38.

Legal Clouds Gather

Several US law firms have been circling. Bronstein, Gewirtz & Grossman flagged the class action on 7 June, while Bragar Eagel & Squire and The Gross Law Firm issued their own reminders. The suit, filed in the United States District Court for the District of New Jersey, covers investors who bought or acquired POET securities between 1 April 2026 and 8:57 a.m. ET on 27 April 2026. The lead-plaintiff deadline is 29 June—just three days after the annual meeting.

The allegations centre on claims of false or misleading statements about the company’s business condition, operational outlook and commercial agreements. A key underlying issue is whether POET should have been classified as a passive foreign investment company under US tax law. The company itself acknowledged in April that it likely qualified as a PFIC for the year ended 31 December 2025. To address that, management plans to redomicile POET in the United States, a move that would remove the foreign-company tag. If shareholder approval is required, the item is expected to be on the agenda for the annual general and special meeting on 26 June.

A Pile of Cash Meets a Production Ambition

None of the legal noise has stopped POET from raising a massive war chest. On 18 May it closed a registered direct placement that brought in gross proceeds of $400,000,020. The company issued 19,047,620 common shares and an equal number of warrants. The funds are earmarked for manufacturing capacity, research and development, targeted acquisitions, the light-source business and general working capital. POET has said it wants to roughly tenfold its wafer production and optical-engine assembly capacity to support the shift toward higher volumes by 2027.

That expansion is anchored by the Lumilens deal announced on 14 May. It includes a supply agreement, a joint development programme for wafer-based photonic integration and an initial purchase order worth $50 million for EOI-based engines. The broader relationship could accumulate more than $500 million in purchases over five years—provided development, qualification and manufacturing scale-up all fall into place.

Revenue Growth, Still Modest

The first quarter offered a glimpse of the underlying commercial progress. POET reported non-recurring engineering and product revenue of $503,389, up from $166,760 in the same period a year earlier and $341,202 in the prior quarter. That is growth, but hardly the kind of top line that justifies a 70%-plus year-to-date rally on its own. The net loss for the quarter was $12.3 million, compared with a net gain of $6.3 million a year ago and a loss of $42.7 million in the prior quarter. The earnings trajectory remains choppy.

Volatility and Technical Levels

The stock’s annualised 30-day volatility stands at 260.31%, underscoring how little room there is for quiet consolidation. The 14-day relative strength index of 48.0 suggests no extreme overbought or oversold conditions. On Friday the stock closed above its 50-day moving average of €8.97 and well above the 200-day line at €6.27. But the distance from the 52-week high of €18.84 is already 44.37%, a sign of how quickly sentiment can shift.

Sector Tailwinds, but Only So Far

External factors may offer some support. Ciena reported second-quarter revenue of $1.57 billion, a 40% year-over-year jump, with its optical networking business generating $1.10 billion. That confirms that optical technology remains in demand for AI infrastructure. Yet the comparison only stretches so far: POET still has to prove it can turn orders into reliable revenue and scalable production. Meanwhile, US inflation data for May are due next week. For a high-beta stock like POET, a hot print could quickly refocus attention on interest-rate expectations and dent risk appetite.

For now, the market is weighing the photonics growth story against twin unknowns: the outcome of the shareholder vote on domicile and the legal proceedings that loom over late June. How those uncertainties resolve will determine whether the next headline comes from the courtroom or the factory floor.